Genomtec S.A. (WSE:GMT)
4.440
-0.120 (-2.63%)
Jul 21, 2026, 5:00 PM CET
Genomtec Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.61 | 4.72 | 6.7 | 4.17 | 4.14 | 1.38 |
Cash & Short-Term Investments | 2.61 | 4.72 | 6.7 | 4.17 | 4.14 | 1.38 |
Cash Growth | -81.18% | -29.49% | 60.64% | 0.73% | 199.30% | -81.06% |
Accounts Receivable | 3.78 | 3.54 | 0.88 | 1.97 | 0.69 | 0.64 |
Inventory | - | - | - | - | 0.11 | 0.19 |
Other Current Assets | 1.04 | 1.05 | 0.91 | 0.5 | 0.06 | 0.04 |
Total Current Assets | 14.85 | 18.61 | 8.49 | 6.65 | 4.99 | 2.26 |
Net Property, Plant & Equipment | 1.68 | 1.73 | 2.61 | 1.75 | 2.19 | 1.07 |
Other Intangible Assets | 3.89 | 4.3 | 5.91 | 7.55 | 4.55 | 0.05 |
Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 6.65 |
Total Assets | 13.03 | 15.36 | 17.04 | 15.97 | 11.76 | 6.69 |
Accounts Payable | 1.36 | 1.53 | 1.18 | 1.27 | 1.12 | 0.32 |
Accrued Expenses | - | - | 0.11 | 0.09 | 0.18 | 0.38 |
Short-Term Debt | 0.45 | 0.44 | 0.42 | 0.39 | 0.37 | 0.3 |
Current Portion of Leases | 1.02 | 1.06 | 0.94 | 0.49 | 0.56 | - |
Other Current Liabilities | 1.37 | 1.09 | 2.84 | 0.91 | 0.1 | 0.1 |
Total Current Liabilities | 4.19 | 4.12 | 5.48 | 3.14 | 2.32 | 1.1 |
Long-Term Debt | - | - | - | - | - | 0.44 |
Long-Term Leases | 0.4 | 0.4 | 1.38 | 1.11 | 1.36 | - |
Other Long-Term Liabilities | 1.42 | 1.63 | 2.58 | 3.42 | 3.19 | 3.11 |
Total Long-Term Liabilities | 1.82 | 2.02 | 3.96 | 4.53 | 4.54 | 0.44 |
Total Liabilities | 6.01 | 6.14 | 9.44 | 7.67 | 6.87 | 4.21 |
Common Stock | 1.51 | 1.51 | 1.33 | 1.23 | 0.94 | 0.82 |
Additional Paid-in Capital | 26.08 | 26.08 | 43.37 | 32.97 | 16.86 | 19.43 |
Retained Earnings | -20.56 | -18.37 | -48.31 | -34.91 | -24.84 | -8.05 |
Shareholders' Equity | 7.02 | 9.21 | 7.6 | 8.3 | 4.89 | 2.48 |
Total Liabilities & Equity | 13.03 | 15.36 | 17.04 | 15.97 | 11.76 | 6.69 |
Total Debt | 1.86 | 1.9 | 2.74 | 1.99 | 2.29 | 0.74 |
Net Cash (Debt) | 0.74 | 2.83 | 3.96 | 2.18 | 1.85 | 0.64 |
Net Cash Growth | -73.66% | -28.68% | 81.61% | 17.83% | 188.97% | -89.78% |
Net Cash Per Share | 0.05 | 0.19 | 0.29 | 0.17 | 0.17 | 0.07 |
Book Value | 7.02 | 9.21 | 7.6 | 8.3 | 4.89 | 2.48 |
Book Value Per Share | 0.46 | 0.61 | 0.56 | 0.66 | 0.45 | 0.28 |
Tangible Book Value | 3.12 | 4.92 | 1.69 | 0.75 | 0.33 | 2.43 |
Tangible Book Value Per Share | 0.21 | 0.32 | 0.12 | 0.06 | 0.03 | 0.27 |